ArticleThe Lancet. Oncology2022
Radiographic progression-free survival in the ACIS trial for prostate cancer - Authors' reply.
Fred Saad et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2022
Fred Saad et al.PubMed ↗Publisher ↗
No numbers read from the abstract.